'Reviews get down to the reality of a product’s performance’
Lab manager Marisa Hildebrandt emphasizes the need for better communication in science and honest product reviews that ‘get past the hype’
Lab manager Marisa Hildebrandt emphasizes the need for better communication in science and honest product reviews that ‘get past the hype’
Watch this on-demand webinar to gain insights into the design and development pipeline for rapid response solutions
Dr. Tullia Bruno shares her multi-omics approach to investigating the role of B cells and tertiary lymphoid structures in the quest for novel cancer therapies
This week, explore topics ranging from checkpoint inhibitor therapies to TIRF microscopy and automated liquid chromatography
Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy
Continued emergence of SARS-CoV-2 variants highlights importance of sequencing for accurate COVID-19 tracking and surveillance
The Simple Plex AAV2 assay combines the scalability and automation of Ella with best-in-class AAV reagents from PROGEN
The company seeks to become a global centre of excellence for whole genome sequencing
Dr. Dallas Flies, Vice President, Discovery Research, NextCure, Inc. discusses the cutting-edge technology transforming the identification of new targets for the development of effective immunotherapeutics
Scientists at University of Warwick demonstrate that levels of a protein – TPD54 – affect movement of cells
Researchers found that longer dosing intervals led to higher antibody levels and a higher proportion of ‘helper’ T cells
The drug aims to treat patients with myelodysplastic syndromes
Immune repertoire assays offer high detection rates of malignant clones, empowering researchers to better assess blood cancers
Gain insights on hot topics ranging from respiratory virus testing to nano and quantum materials and automated LC-MS/MS workflows
Discover the impact of the COVID-19 pandemic on a clinical research facility and the future of clinical trial recruitment
The authorization enables emergency use of Actemra/RoActemra for the treatment of COVID-19 in hospitalized adult and pediatric patients
The novel lipid nanoparticles for mRNA delivery will enhance thermostability, biodegradability and safety, paving the way for new off-the-shelf therapies
VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies